热门资讯> 正文
Autonomix获得涵盖专有导管技术的专利
2024-04-16 21:47
- Autonomix Medical (NASDAQ:AMIX) on Tuesday announced that the U.S. patent office issued a patent entitled “Systems and Methods for Treating Cancer and/or Augmenting Organ Function.”
- The issued patent is directed to technology including, but not limited to, systems, methods, and devices for interventionally treating cancerous tumors and cancer-related pain, the company added.
- AMIX said it is initially advancing the development of its technology to address pancreatic cancer-related pain.
- Source: Press Release
More on Autonomix Medical, Inc.
- Spotlight On Nvidia, Walmart, Palo Alto Networks And CAGNY Conference
- Autonomix announces positive preclinical study for its catheter-based sensing technology
- Financial information for Autonomix Medical, Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
